Post hoc analysis of TheraP in docetaxel-refractory mCRPC: treatment-emergent clonal haematopoiesis was more common after 177Lu-PSMA-617 than cabazitaxel (62% vs 40%) among 107 patients with paired samples, with greater clone expansion.
Secondary analysisn = 178
Munzur et al. Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer